| Dr Alizabeth Lechi Truong, MD | |
|
1400 Pottery Ave, Port Orchard, WA 98366-3711 | |
| (360) 895-5000 | |
| Not Available |
| Full Name | Dr Alizabeth Lechi Truong |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 1400 Pottery Ave, Port Orchard, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801898598 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | A68200 (California) | Secondary |
| 207N00000X | Dermatology | MD60604631 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
Johnnie Esco died after a 13-day stay at the El Dorado Care Center in Placerville. Her death on March 7, 2008, led to a contentious civil lawsuit, investigations by California's Department of Justice and Department of Public Health – and the exhumation of her body from Arlington National Cemetery. Last week, amid inquiries from The Bee, the state Department of Justice reopened its criminal investigation into Johnnie Esco's treatment at the facility.
"Controlling systems-like the navigation system in a car-by voice is very convenient. However, one must ask the question of how best to design voice controls. Especially when we are handling two tasks simultaneously, cognitive control plays a decisive role," says Vera Demberg, professor of computer science and computational linguistics at Saarland University.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
› Verified 2 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
Johnnie Esco died after a 13-day stay at the El Dorado Care Center in Placerville. Her death on March 7, 2008, led to a contentious civil lawsuit, investigations by California's Department of Justice and Department of Public Health – and the exhumation of her body from Arlington National Cemetery. Last week, amid inquiries from The Bee, the state Department of Justice reopened its criminal investigation into Johnnie Esco's treatment at the facility.
"Controlling systems-like the navigation system in a car-by voice is very convenient. However, one must ask the question of how best to design voice controls. Especially when we are handling two tasks simultaneously, cognitive control plays a decisive role," says Vera Demberg, professor of computer science and computational linguistics at Saarland University.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alizabeth Lechi Truong, MD 1400 Pottery Ave, Port Orchard, WA 98366-3711 Ph: (360) 895-5000 | Dr Alizabeth Lechi Truong, MD 1400 Pottery Ave, Port Orchard, WA 98366-3711 Ph: (360) 895-5000 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
Johnnie Esco died after a 13-day stay at the El Dorado Care Center in Placerville. Her death on March 7, 2008, led to a contentious civil lawsuit, investigations by California's Department of Justice and Department of Public Health – and the exhumation of her body from Arlington National Cemetery. Last week, amid inquiries from The Bee, the state Department of Justice reopened its criminal investigation into Johnnie Esco's treatment at the facility.
"Controlling systems-like the navigation system in a car-by voice is very convenient. However, one must ask the question of how best to design voice controls. Especially when we are handling two tasks simultaneously, cognitive control plays a decisive role," says Vera Demberg, professor of computer science and computational linguistics at Saarland University.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
› Verified 2 days ago
Dr. Minh-tuan Richard Hoang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1400 Pottery Ave, Port Orchard, WA 98366 Phone: 360-895-5000 Fax: 360-895-5034 | |
Dr. Christina Anne Hardaway, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 450 S Kitsap Blvd Ste 250, Port Orchard, WA 98366 Phone: 360-782-3000 Fax: 360-782-3040 |